Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

Pharmacy Guide

Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.

← Back to all medicines

Simple Linctus BP

⚠ This medicine appears to have been discontinued

The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.

If you were prescribed this medicine, other products containing Citric acid monohydrate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.

Active substance: Citric acid monohydrate

Equivalent medicines (same active substance, strength and form)

Source: electronic medicines compendium (emc)
Official leaflet: Read the PIL on emc

Possible side effects

Like all medicines, this medicine can cause side effects,

3. Further information

44! you accidentally take too much see a doctor straight

although not everybody gets them. Hypersensitivty/alergic away. Take the pack with you to show which medicine you reactions are possible with this product (frequency

have swallowed.

unknown).

*Do not use after theexpr date. The expiry date reters to

diarrhoea.

disposal.

IT taken excessively above the stated dose, glycerci present – tha tast day of that month

ITyou

notke any side effects, stop use and tell your doctor

r7 parma

They wil tell you what to do.

"

Reporting of side effects

ITyou gat any side effects, talkto your doctor, pharmacist of nurse. This Includes any passive side efiects not listed

In this leaflet. You can also report side effects directly Wa

ingredient

the Oy 125mg,

is:

per Sent is: citric acki rmonohydrate

The other ingredients are: aniseed flavour (contains

propylene glycol), glycerol (642). sucrose, sodium benzoate (E211) and purified water.

What the medicine looks like

the Yelow Card Scheme at www.rihra.gov.ukyellowcard = simple Linctus is a colourless syrupy liquid. of saarch for MHRA Yellow Card' In theGooge Play or

itis supplied In a 200m! bottie.

Apple App Store.

This label was last revised in July 2020.

reporting

site effects

you can hap provide more

whoration on the satety of thismadkine.

2774882007

Frequently asked questions about Simple Linctus BP

What is the active substance in Simple Linctus BP?

The active substance in Simple Linctus BP is citric acid monohydrate.

Are there equivalent medicines to Simple Linctus BP?

Medicines with the same active substance, strength and form include: Simple Linctus Paediatric BP, Simple Linctus Paediatric Sugar Free, Simple Linctus Paediatric Sugar Free. In total there are 5 equivalent products. They are interchangeable only if your prescriber or pharmacist says so.

Where does this information come from?

This leaflet reproduces the patient information leaflet approved for Simple Linctus BP, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.

Can I get Simple Linctus BP without a prescription?

Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.

About this leaflet

The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.

Medical disclaimer: This page is for information only and does not replace advice from your doctor or pharmacist. Always read the leaflet supplied with your medicine. If you are unwell, call NHS 111; in an emergency, call 999.

Medicines with the same active substance: Citric acid monohydrate (5 medicines)
See every medicine containing this substance, or browse the full A–Z of active substances.
⚕For healthcare professionals — Summary of Product Characteristics (SmPC)Full SmPC: dosage, interactions, contraindications, warnings+
Technical information intended for healthcare professionals (doctors and pharmacists). The Summary of Product Characteristics (SmPC) is the official document approved by the MHRA/EMA. It does not replace the patient leaflet or a doctor’s advice.

4.1. Therapeutic indications

For relief of the symptoms of coughs.

4.2. Posology and method of administration

Oral.

Recommended Doses

Adults, the elderly and children over 12 years: One 5ml spoonful, repeated up to four times per day.

Children under 12 years: Not recommended.

4.3. Contraindications

None Known.

4.4. Special warnings and precautions for use

Keep out of the reach of children.

Not suitable for children under 12 years.

This product contains 4g of sucrose per dose. To be taken into account in people with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

This medicine contains less than 1mmol sodium (23 mg) per 5ml dose, that is to say essentially 'sodium-free'. This medicine contains 2.5mg sodium benzoate per 5ml dose.

4.5. Interaction with other medicinal products and other forms of interaction

None known.

4.6. Pregnancy and lactation

No adverse effects are known for the product, however, as with all medicines use should be avoided during pregnancy unless recommended by a doctor.

4.7. Effects on ability to drive and use machines

None known.

4.8. Undesirable effects

Tabulated list of adverse reaction(s)

Adverse reactions frequency are defined using the following convention:

Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data).

System organ class (MedDRA)

Frequency

Adverse event

Immune System Disorders

Not known

Hypersensitivity

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

4.9. Overdose

Overdose with this preparation is unlikely to occur due to the low concentrations of the ingredients, however, in the event, treatment should be symptomatic.

💬 Ask about this leaflet

Ask anything about Simple Linctus BP. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.

Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.

Pharmacies in major towns and cities — see the list
Pharmacies by county and region — see the full list

Browse all 2,009 towns and cities →